[Effect of the administration of silymarin on serum lipid levels].
D000328:Adult; D002635:Chenodeoxycholic Acid / Q000097:blood; D002793:Cholic Acids / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012838:Silymarin / Q000627:therapeutic use*
D002793:Cholic Acids; D005419:Flavonoids; D008055:Lipids; D012838:Silymarin; D002635:Chenodeoxycholic Acid
Effetto della somministrazione di silimarina sui livelli dei lipidi sierici.